Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Systemic sclerosis--challenges for clinical practice.

McMahan ZH, Hummers LK.

Nat Rev Rheumatol. 2013 Feb;9(2):90-100. doi: 10.1038/nrrheum.2012.191. Epub 2012 Nov 13. Review.

PMID:
23147899
2.

Imaging lung disease in systemic sclerosis.

Strollo D, Goldin J.

Curr Rheumatol Rep. 2010 Apr;12(2):156-61. doi: 10.1007/s11926-010-0095-0. Review.

3.

Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.

Mangat P, Conron M, Gabbay E, Proudman SM; Pulmonary Interstitial Vascular Organisational Taskforce (PIVOT).

Intern Med J. 2010 Jul;40(7):494-502. doi: 10.1111/j.1445-5994.2009.01990.x. Epub 2009 May 21.

PMID:
19460060
4.

Scleroderma lung disease.

Le Pavec J, Launay D, Mathai SC, Hassoun PM, Humbert M.

Clin Rev Allergy Immunol. 2011 Apr;40(2):104-16. doi: 10.1007/s12016-009-8194-2.

PMID:
20063208
5.

Clinical approach to scleroderma.

White B.

Semin Cutan Med Surg. 1998 Sep;17(3):213-8.

PMID:
9759679
6.

Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary?

Foocharoen C, Mahakkanukrauh A, Pussadhamma B, Netwijitpan S, Suwannaroj S, Nanagara R.

J Clin Rheumatol. 2014 Aug;20(5):268-74. doi: 10.1097/RHU.0000000000000120.

PMID:
25036561
7.

Pulmonary arterial hypertension associated with systemic sclerosis.

Mathai SC, Hassoun PM.

Expert Rev Respir Med. 2011 Apr;5(2):267-79. doi: 10.1586/ers.11.18. Review.

8.

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.

Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.

PMID:
22169458
9.

Management of systemic sclerosis: the art and science.

Stone JH, Wigley FM.

Semin Cutan Med Surg. 1998 Mar;17(1):55-64. Review.

PMID:
9512108
10.

Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.

Pope J, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research Group, Baron M.

J Rheumatol. 2012 Mar;39(3):524-31. doi: 10.3899/jrheum.110121. Epub 2012 Jan 15.

PMID:
22247347
11.

The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Saketkoo LA, Magnus JH, Doyle MK.

Am J Med Sci. 2014 Jan;347(1):54-63. doi: 10.1097/MAJ.0b013e3182a55d24. Review.

12.

[Lung involvement in systemic sclerosis].

Posa M, Stelle M, Lador F, Chizzolini C.

Rev Med Suisse. 2015 Apr 8;11(469):802-6. French.

PMID:
26040160
13.

Systemic sclerosis. A clinical overview.

Generini S, Fiori G, Moggi Pignone A, Matucci Cerinic M, Cagnoni M.

Adv Exp Med Biol. 1999;455:73-83. Review.

PMID:
10599326
14.

Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.

Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C.

Microvasc Res. 2015 May;99:92-5. doi: 10.1016/j.mvr.2015.03.005. Epub 2015 Apr 2.

PMID:
25842153
15.

Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening.

Denton CP, Hachulla E.

Eur Respir Rev. 2011 Dec;20(122):270-6. doi: 10.1183/09059180.00006111. Review.

16.

Lung transplantation in patients with scleroderma.

De Cruz S, Ross D.

Curr Opin Rheumatol. 2013 Nov;25(6):714-8. doi: 10.1097/01.bor.0000434670.39773.a8. Review.

PMID:
24061075
17.

Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.

Thakkar V, Nikpour M, Stevens WM, Proudman SM.

Intern Med J. 2015 Mar;45(3):248-54. doi: 10.1111/imj.12691. Review.

PMID:
25735576
18.

Determinants of morbidity and mortality of systemic sclerosis in Canada.

Al-Dhaher FF, Pope JE, Ouimet JM.

Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15.

PMID:
18706680
19.

Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease.

Della Rossa A, D'Ascanio A, Barsotti S, Stagnaro C, Mosca M.

Scand J Rheumatol. 2016 Oct;45(5):408-11. doi: 10.3109/03009742.2015.1127411. Epub 2016 Mar 7.

PMID:
26948487
20.

Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.

Yaqub A, Chung L.

Curr Rheumatol Rep. 2013 Jan;15(1):302. doi: 10.1007/s11926-012-0302-2. Review.

PMID:
23292818

Supplemental Content

Support Center